GlassScriptPhysician profile
Sarah Davis
NPI 1932155785
$8,856.76
in general payments reported to CMS, 2019-2025
35 companies · $3,008 in 2025
The $3,008 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $1,057 · 2023: $2,258 · 2024: $2,329 · 2025: $3,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,017 · Travel and Lodging: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,016.87 |
| Travel and Lodging | $577.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,413.69 | 2021-2025 | |
| Bard Peripheral Vascular, INC. | $862.32 | 2025 | Venclose Maven Catheter |
| Edwards Lifesciences Corporation | $786.86 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $740.64 | 2022-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $480.10 | 2022-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $452.71 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $440.65 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $398.48 | 2022-2025 | Lokelma, Farxiga, Wainua |
| Atricure, INC. | $396.17 | 2022-2024 | |
| Abbott Laboratories | $292.08 | 2023-2024 | Mitraclip, Cardiomems |
| Alnylam Pharmaceuticals INC. | $276.19 | 2022-2025 | Amvuttra, Onpattro |
| Janssen Pharmaceuticals, INC | $266.02 | 2023-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $255.53 | 2021-2023 | Optimizer |
| Pfizer INC. | $234.02 | 2022-2025 | |
| Recor Medical INC | $210.47 | 2024 | Paradise Renal Denervation System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $203.68 | 2024-2025 | Wegovy |
| Esperion Therapeutics, INC. | $199.25 | 2022-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $170.16 | 2023-2024 | |
| Boston Scientific Corporation | $151.77 | 2025 | Watchman Flx |
| Tactile Systems Technology INC | $94.27 | 2024 | Entre Plus, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $78.43 | 2022-2025 | Verquvo, Capvaxive |
| Biotronik INC. | $75.24 | 2022-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Daiichi Sankyo INC. | $61.41 | 2022-2023 | Injectafer |
| Amarin Pharma, INC. | $44.80 | 2021-2022 | |
| Biosense Webster, INC. | $43.57 | 2024 | Carto 3 |
| Bayer Healthcare Pharmaceuticals INC. | $34.65 | 2025 | |
| Lilly USA, LLC | $31.50 | 2025 | Zepbound, Mounjaro |
| Siemens Medical Solutions USA, INC. | $26.84 | 2025 | Artis Q Floor |
| Kestra Medical Technology Services, INC. | $24.74 | 2023 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $24.41 | 2025 | Evkeeza |
| Baxter Healthcare | $21.86 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Iovance Biotherapeutics, INC. | $21.38 | 2025 | Amtagvi |
| Imperative Care, INC | $15.09 | 2025 | Symphony Catheter |
| Kci USA, INC. | $14.89 | 2023 | Prevena, V.A.C.Ulta |
| Kowa Pharmaceuticals America, INC. | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.